George Marzouka, MD

A clinician shares his experience with palliative care in cardiology and makes the case for offering palliative care services earlier in pulmonary arterial hypertension.

Results of the FOURIER trial, presented at the 2017 ACC Scientific Sessions, raise questions about the efficacy of PCSK9 inhibitors as long-term therapy for patients with atherosclerotic CVD.

A cardiologist contemplates on the value that preoperative “clearance” brings to patients and their surgeons.

Researchers argue that elevated coronary artery calcium scores increase the risk of adverse cardiovascular events even in young patients.